Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» U.S. patent office rules against Amgen Humira challenge
U.S. patent office rules against Amgen Humira challenge
U.S. patent office rules against Amgen Humira challenge
Submitted by
admin
on January 14, 2016 - 8:49pm
Source:
Yahoo/Reuters
News Tags:
patents
Amgen
Humira
generics
AbbVie
Headline:
U.S. patent office rules against Amgen Humira challenge
Do Not Allow Advertisers to Use My Personal information
